Skip to main content
. 2015 Apr 5;128(7):963–968. doi: 10.4103/0366-6999.154318

Table 4.

Analysis outcomes of adverse events

Adverse events Number of studies RR 95% CI P
Urinary tract infection 4 1.48 1.20–1.81 0.0002
Hematuria 4 1.81 1.00–1.34 0.0500
Urinary retention 4 5.87 3.61–9.56 <0.0001

CI: Confidence interval; RR: Relative risk.